Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apply for the Fierce AI Innovation Awards - Submissions close Thursday, June 18
ICON
CRO
Icon ends accounting investigation, finds overstated revenue
Irish CRO Icon has concluded its investigation into its accounting practices and restated its consolidated financials for 2023 and 2024.
Will Maddox
May 28, 2026 10:31am
Icon opens Texas research unit and new satellite clinics
May 13, 2026 1:52pm
Banyan BioInnovations launches with $100M, Icon collab
May 7, 2026 2:13pm
Icon, Advarra team up to optimize trials, expand access
Mar 24, 2026 4:52pm
Icon reveals accounting investigation, withdraws 2025 guidance
Feb 12, 2026 11:12am
Merck KGaA lands new R&D chief—Chutes & Ladders
Sep 5, 2025 8:30am